Major Extremity Trauma Research Consortium

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Jul 7, 2026

Completed

Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (Vancomycin Study)

Jul 3, 2026

Completed

Patient Response to an Integrated Orthotic and Rehabilitation Initiative for Traumatic Injuries for the Military Treatment Facilities (PRIORITI-MTF)

Earlier

Jun 1, 2023TrialEvaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)

May 30, 2023TrialPO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

Sep 14, 2021TrialEffect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures

May 26, 2021TrialEffect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial

May 11, 2021TrialTopical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA

May 7, 2021TrialEvaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT

1 more events

Apr 24, 2017TrialPREVENTion of Clot in Orthopaedic Trauma

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)